Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  HIV Infection

  Free Subscription


1 Am J Epidemiol
1 BMC Neurol
1 BMC Pediatr
3 Clin Infect Dis
1 J Infect Dis
1 J Med Virol
2 J Virol
1 Lancet
4 Lancet Infect Dis
1 Nat Med
1 Nature
14 PLoS One
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. KAUPPINEN KJ, Aho I, Sutinen J
    Switching from tenofovir alafenamide to tenofovir disoproxil fumarate improves lipid profile and protects from weight gain.
    AIDS. 2022 Jun 22. pii: 00002030-990000000-00035.
    PubMed         Abstract available

  2. FITCH KV, Mccallum SA, Erlandson KM, Overton ET, et al
    Diet in a global cohort of adults with HIV at Low to Moderate Traditional Cardiovascular Disease Risk.
    AIDS. 2022 Jul 27. pii: 00002030-990000000-00079.
    PubMed         Abstract available

  3. PALA AN, Kempf MC, Konkle-Parker D, Wilson TE, et al
    Intersectional stigmas are associated with lower viral suppression Rates and ART adherence among Women living with HIV.
    AIDS. 2022 Jul 26. pii: 00002030-990000000-00075.
    PubMed         Abstract available

  4. MANN LM, Le Guillou A, Goodreau SM, Marcus JL, et al
    Correlations between community-level HIV preexposure prophylaxis coverage and individual-level sexual behaviors among US men who have sex with men.
    AIDS. 2022 Jul 26. pii: 00002030-990000000-00078.
    PubMed         Abstract available

  5. YAZDANI K, Salters K, Shen T, Dolguikh K, et al
    A twenty-year population-based study of all-cause and cause-specific mortality among people with concurrent HIV and psychotic disorders.
    AIDS. 2022 Jul 26. pii: 00002030-990000000-00076.
    PubMed         Abstract available

  6. LESKO CR, Edwards JK, Hanna DB, Mayor AM, et al
    Longitudinal HIV care outcomes by gender identity in the United States.
    AIDS. 2022 Jul 21. pii: 00002030-990000000-00074.
    PubMed         Abstract available

  7. WOOD BR, Stekler JD
    Baseline HIV genotype drug resistance testing: is it time for more or less?
    AIDS. 2022;36:1449-1451.

  8. SCHNEIDER JA, Bouris A
    Ryan White programming that primarily supports clinical care falls short when core people needs are not met: further evidence from the medical monitoring project.
    AIDS. 2022;36:1453-1456.

  9. STAPLETON JT, Bedimo RJ, Guaraldi G
    Switch back from TAF to TDF or rather switch forward from metabolic toxicities of drugs to metabolic health of people living with HIV.
    AIDS. 2022;36:1457-1459.

  10. LURAIN K, Uldrick TS, Navarro JT
    Leveraging fine-needle aspiration to improve HIV-associated lymphoma diagnostic capacity in resource-limited settings.
    AIDS. 2022;36:1461-1463.

  11. CHAMMARTIN F, Kusejko K, Pasin C, Trkola A, et al
    Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIV.
    AIDS. 2022;36:1465-1468.
    PubMed         Abstract available

  12. SEBASTIANI G, Sebastiani G
    Fatty liver in children with HIV: a clinical iceberg?
    AIDS. 2022;36:1469-1471.

  13. CARRASCO I, Olveira A, Lancharro A, Escosa L, et al
    Fatty liver disease in children living with HIV: a ghostly iceberg.
    AIDS. 2022;36:1471-1472.

  14. PHILLIPS AN, Sibanda E, Sikwese K, Bansi-Matharu L, et al
    Enabling timely HIV postexposure prophylaxis access in sub-Saharan Africa.
    AIDS. 2022;36:1473-1475.

  15. BARNETT SK, Armas-Kolostroubis L, Sension M, Riedel DJ, et al
    Cabotegravir-rilpivirine treatment initiation in a nonvirologically suppressed patient.
    AIDS. 2022;36:1475-1476.

    Am J Epidemiol

  16. BRUMMEL SS, Van Dyke RB, Patel K, Purswani M, et al
    Analyzing Longitudinally Collected Viral Load Measurements in Youth With Perinatally-Acquired HIV Infection: Problems and Possible Remedies.
    Am J Epidemiol. 2022 Jul 22. pii: 6648774. doi: 10.1093.
    PubMed         Abstract available

    BMC Neurol

  17. LIU J, Liu J, Su X, Yang L, et al
    Amphotericin B plus fluorocytosine combined with voriconazole for the treatment of non-HIV and non-transplant-associated cryptococcal meningitis: a retrospective study.
    BMC Neurol. 2022;22:274.
    PubMed         Abstract available

    BMC Pediatr

  18. SIMMS V, McHugh G, Dauya E, Bandason T, et al
    Growth improvement following antiretroviral therapy initiation in children with perinatally-acquired HIV diagnosed in older childhood in Zimbabwe: a prospective cohort study.
    BMC Pediatr. 2022;22:446.
    PubMed         Abstract available


  19. PATEL A, Bilinska J, Tam JCH, Da Silva Fontoura D, et al
    Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series.
    BMJ. 2022;378:e072410.
    PubMed         Abstract available

    Clin Infect Dis

  20. BUI HTM, Adamson PC, Le GM, Klausner JD, et al
    Pharyngeal Chlamydia trachomatis in Men Who Have Sex With Men in an HIV Pre-Exposure Prophylaxis Program in Hanoi, Vietnam.
    Clin Infect Dis. 2022 Jul 27. pii: 6650382. doi: 10.1093.

  21. CHAPLIN B, Agbaji O, Nieva HR, Olatunde B, et al
    The Timeliness of Point of Care Viral Load Results Improves HIV Monitoring in Nigeria.
    Clin Infect Dis. 2022 Jul 24. pii: 6649441. doi: 10.1093.
    PubMed         Abstract available

  22. WEI F, Goodman MT, Xia N, Zhang J, et al
    Incidence and clearance of anal human papillomavirus infection in 16 164 individuals, according to HIV status, gender, and male sexuality: an international pooled analysis of 34 longitudinal studies.
    Clin Infect Dis. 2022 Jul 23. pii: 6649069. doi: 10.1093.
    PubMed         Abstract available

    J Infect Dis

  23. BABALOLA CM, Siebert JC, Kallapur SG, Maecker HT, et al
    Discrete Plasma Cytokine Profiles among Pregnant Women in Botswana by Chlamydia trachomatis infection, HIV status, and Gestational age.
    J Infect Dis. 2022 Jul 25. pii: 6649668. doi: 10.1093.

    J Med Virol

  24. RUPASINGHE D, Choi JY, Yunihastuti E, Kiertiburanakul S, et al
    Factors associated with high alanine aminotransferase (ALT) and cirrhosis in people living with HIV on combination antiretroviral treatment (cART) in the Asia-Pacific.
    J Med Virol. 2022 Jul 22. doi: 10.1002/jmv.28019.
    PubMed         Abstract available

    J Virol

  25. LIN J, Law R, Korosec CS, Zhou C, et al
    Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.
    J Virol. 2022 Jun 14:e0050922. doi: 10.1128/jvi.00509.
    PubMed         Abstract available

  26. RUDICELL RS, Piel AK, Stewart F, Moore DL, et al
    Correction for Rudicell et al., "High Prevalence of Simian Immunodeficiency Virus Infection in a Community of Savanna Chimpanzees".
    J Virol. 2022 Jul 26:e0045122. doi: 10.1128/jvi.00451.


  27. MAYER KH, Phanuphak N, Mgodi N, Grinsztejn B, et al
    New HIV prevention approaches: promise, praxis, and pitfalls.
    Lancet. 2022;400:257-259.

    Lancet Infect Dis

  28. AYLES H, Mureithi L, Simwinga M
    The state of tuberculosis in South Africa: what does the first national tuberculosis prevalence survey teach us?
    Lancet Infect Dis. 2022;22:1094-1096.

    Reaching the vulnerable without stigma.
    Lancet Infect Dis. 2022;22:1091.

  30. PETERS RPH, Chico RM, Rowley J, Low N, et al
    Estimating the global burden of sexually transmitted infections.
    Lancet Infect Dis. 2022;22:1112-1113.

  31. BURKI T
    Guidelines for visceral leishmaniasis and HIV co-infection.
    Lancet Infect Dis. 2022;22:1124-1125.

    Nat Med

    Long-acting agents for HIV treatment and prevention.
    Nat Med. 2022 Jul 22. pii: 10.1038/s41591-022-01917.


  33. Small payments to low-income people lead to big drops in HIV deaths.
    Nature. 2022;607:639.

    PLoS One

  34. DAMTIE Y, Kefale B, Yalew M, Arefaynie M, et al
    HIV risk behavior and associated factors among people living with HIV/AIDS in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0269304.
    PubMed         Abstract available

  35. SOSENKO FL, Bramley G
    Smartphone-based Respondent Driven Sampling (RDS): A methodological advance in surveying small or 'hard-to-reach' populations.
    PLoS One. 2022;17:e0270673.
    PubMed         Abstract available

  36. FLO M, Carrion F, Olivero-Deibe N, Bianchi S, et al
    Kinetics of Bovine leukemia virus aspartic protease reveals its dimerization and conformational change.
    PLoS One. 2022;17:e0271671.
    PubMed         Abstract available

  37. FAUK NK, Mwanri L, Hawke K, Ward PR, et al
    Traditional Human Immunodeficiency Virus treatment and family and social influence as barriers to accessing HIV care services in Belu, Indonesia.
    PLoS One. 2022;17:e0264462.
    PubMed         Abstract available

  38. LAHOOD A, Rahman R, McKenna L, Frick M, et al
    Comparing timelines and evidence available to support new TB, HIV, and HCV drug approvals: The same, only different.
    PLoS One. 2022;17:e0271102.
    PubMed         Abstract available

  39. BANTIE B, Kassaw Yirga G, Abate MW, Amare AT, et al
    Delayed ART initiation in "Test and Treat era" and its associated factors among adults receiving antiretroviral therapy at public health institutions in Northwest Ethiopia: A multicenter cross-sectional study.
    PLoS One. 2022;17:e0271127.
    PubMed         Abstract available

  40. SENDAULA E, Buwembo M, Opio D
    Clinical profile of HIV-infected adults receiving a holistic approach of care model in Nakawa, Kampala District.
    PLoS One. 2022;17:e0272039.
    PubMed         Abstract available

  41. MOKUA S, Maloba M, Wexler C, Goggin K, et al
    Evaluating the efficacy of the HITSystem 2.1 to improve PMTCT retention and maternal viral suppression in Kenya: Study protocol of a cluster-randomized trial.
    PLoS One. 2022;17:e0263988.
    PubMed         Abstract available

  42. SOTO PC, Terry VH, Lewinski MK, Deshmukh S, et al
    HIV-1 latency is established preferentially in minimally activated and non-dividing cells during productive infection of primary CD4 T cells.
    PLoS One. 2022;17:e0271674.
    PubMed         Abstract available

  43. SOMEFUN OD, Olamijuwon E
    Community structure and timing of sexual activity among adolescent girls in Nigeria.
    PLoS One. 2022;17:e0269168.
    PubMed         Abstract available

  44. KANG JY, Farkhad BF, Chan MS, Michels A, et al
    Spatial accessibility to HIV testing, treatment, and prevention services in Illinois and Chicago, USA.
    PLoS One. 2022;17:e0270404.
    PubMed         Abstract available

  45. SEMPA JB, Grebe E, Welte A
    Quantitative interpretation of Sedia LAg Assay test results after HIV diagnosis.
    PLoS One. 2022;17:e0271763.
    PubMed         Abstract available

  46. MAPALA L, Bekker A, Dramowski A
    Evaluating the appropriateness of laboratory testing and antimicrobial use in South African children hospitalized for community-acquired infections.
    PLoS One. 2022;17:e0272119.
    PubMed         Abstract available

  47. SCHWITTERS A, McCracken S, Frederix K, Tierney R, et al
    High HIV prevalence and associated factors in Lesotho: Results from a population-based survey.
    PLoS One. 2022;17:e0271431.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  48. LY PT, Xu S, Wirawan M, Luo D, et al
    ZAP isoforms regulate unfolded protein response and epithelial- mesenchymal transition.
    Proc Natl Acad Sci U S A. 2022;119:e2121453119.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.